Transcriptome analysis reveals the anticancer effects of fenbendazole on ovarian cancer: an in vitro and in vivo study
Abstract New treatment strategies for ovarian cancer, which is the deadliest female reproductive tract malignancy, are urgently needed. Here, we investigated the anticancer effects of fenbendazole (FBZ), a benzimidazole compound, on the regulation of apoptosis and mitotic catastrophe in A2780 and SK...
Saved in:
Main Authors: | Xin Wang, Wenda Tian, Ning Wang, Xiangqun Yang, Zhenyan Liu, Lvzhou Li, Taoyu Zhao, Chuanlin Wang, Hongping Zhang, Hongying Yang, Yue Jia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-024-13361-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unleashing the Power of Cold Atmospheric Plasma: Inducing Mitochondria Damage‐Mediated Mitotic Catastrophe
by: Shengjie Peng, et al.
Published: (2024-12-01) -
A convergent fabrication of programmed pH/reduction-responsive nanoparticles for efficient dual anticancer drugs delivery for ovarian cancer treatment
by: Haiyan Zhang, et al.
Published: (2023-12-01) -
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
by: Mary P. Udumula, et al.
Published: (2024-11-01) -
Psychological stressors involved in the pathogenesis of premature ovarian insufficiency and potential intervention measures
by: Ying-Pei Xu, et al.
Published: (2024-12-01) -
Overview of the evaluation of the destructive effect of procarbazine on the ovarian reserve in the apoptotic, inflammatory, and oxidative pathways
by: Kezban Kartlasmis, et al.
Published: (2024-12-01)